Factor XI and high molecular weight kininogen were found associated in normal human plasma at mol wt 380,000 as assessed by gel filtration on Sephadex G-200. The molecular weight of Factor XI in high molecular weight kininogen-deficient plasma was 175,000, the same value obtained for purified Factor XI. When high molecular weight kininogen-deficient plasma was reconstituted with purified high molecular weight kininogen, all of the Factor XI was then found at mol wt 380,000. Complex formation was also demonstrable upon incubation of Factor XI and highly purified high molecular weight kininogen. This complex was distinct from the prekallikrein-high molecular weight kininogen complex; thus high molecular weight kininogen forms bimolecular complexes with either Factor XI or prekallikrein but does not form a trimolecular complex that includes both Factor XI and prekallikrein. Neither Hageman factor nor plasminogen were found associated with high molecular weight kininogen; binding to high molecular weight kininogen appeared to be a specific property of the Hageman factor substrates.
INTRODUCTION
Each protein of the plasma kinin-forming system has been shown to function as a coagulation factor. Thus, plasmas that are deficient in Hageman factor, prekallikrein, or high molecular weight (HMW)l kininogen exhibit a prolonged partial thromboplastin time which reflects their relative rate of Hageman factor activation (1) (2) (3) (4) (5) (6) (7) (8) (9) . HMW kininogen has been shown to function as a cofactor in the activation of prekallikrein by Hageman factor as well as the activation of Hageman factor by kallikrein (10) (11) (12) (13) (14) . We have recently demonstrated that prekallikrein and HMW kininogen normally circu-late as a complex (15) and proposed that such binding might facilitate the trimolecular interaction that takes place upon the surface. Because the activation of Factor XI, the other Hageman factor substrate, is also augmented by HMW kininogen (10) (11) (12) (13) 16) , we have examined the possibility that Factor XI forms a complex with HMW kininogen (17) . In this paper we show that Factor XI is bound to HMW kininogen in whole plasma and that such binding is also demonstrable utilizing highly purified components. and passed over a 20 x 100-cm column of QAE-Sephadex equilibrated with the same buffer. The effluent, containing a mixture of proteins of gamma globulin mobility was then fractionated by sequential chromatography on SP-Sephadex and Sephadex G-150. In the gel filtration experiments described herein Factor XI was utilized after the Sephadex G-150 step which prevented any aggregation of Factor XI (observed upon recycling purified Factor XI) and the IgG was followed as an internal marker. The Factor XI preparation contained 5.0 U Factor XI/ml if 1 U is defined as the concentration of Factor XI in normal human plasma. It contained no detectable Hageman factor, prekallikrein, HMW kininogen, or plasminogen when assayed at a concentration of 25 U/ml. HMW kininogen. HMW kininogen was isolated from 2 liters of normal plasma by chromatography on QAESephadex A-50, ammonium sulfate precipitation, fractionation on SP-Sephadex, and Sephadex G-200 gel filtration according to the method of Habal et al. (22) . A small percentage of aggregated HMW kininogen was identified and only the major peak found at an apparent mol wt 210,000 was utilized (23) .
METHODS
The preparation was quantitated functionally by its ability to selectively correct the coagulation defect in Williams trait plasma (6) and it was free of any detectable Hageman Ouchterlony analysis of column fractions (27) Fig. 3 . Factor XI was found at mol wt 380,000 and prekallikrein was found at mol wt 285,000; there was no detectable peak of activity containing both Hageman factor substrates suggesting that they each bind to different molecules of HMW kininogen. Hageman factor was found at mol wt 115,000 indicating that it is not complexed to HMW kininogen (15) . Because Factor XIa (29, 30) , kallikrein (29) , and plasmin (31) can each function as an activator 3 of Hageman factor, the possibility that plasminogen circulates bound to HMW kininogen was also examined. When assessed functionally, all the plasminogen was found at mol wt 95,000, suggesting that there was no plasminogen-HMW kininogen complex. However, plasminogen is present in plasma at approximately three times the concentration of HMW FIGURE 4 Sephadex G-200 gel filtration of 2 ml of Factor XI (5 U/ml) (upper panel), 2 ml of purified HMW kininogen (50 U/ml) (center panel), and a mixture of 2 ml Factor XI plus 2 ml HMW kininogen (bottom panel). Buffer was added so that a total of 4.0 ml was applied to the column in each kininogen, and if a fraction thereof were complexed, the inhibitors present at mol wt 200,000-300,000 might have inhibited any plasmin generated in our assay. We therefore assayed the column for plasminogen by Ouchterlony analysis and a peak of antigenic plasminogen was found corresponding to the functional activity although none was found in the region of the prekallikrein-HMW kininogen complex. Furthermore, when fractions 55-70 were pooled and concentrated 10-fold, the concentrate had no detectable antigenic plasminogen.
To confirm the ability of Factor XI to bind to HMW kininogen, the Sephadex G-200 gel filtration was performed with highly purified components. Purified Factor XI alone was found to contain a small fraction of aggregated material. We therefore utilized Factor XI after the Sephadex G-150 gel filtration step before removal of IgG by immunoadsorption. As shown in the upper panel of Fig. 4 Because kallikrein, Factor XIa, and plasmin can each activate Hageman factor, we considered the possibility that plasminogen is also bound to HMW kininogen; however, no binding was evident. We have recently reported that Factor XIa-HMW kininogen activates surface-bound Hageman factor and that the HMW kininogen augments the subsequent activation of prekallikrein. However, no such augmentation by HMW kininogen was evident when plasmin was used to activate the Hageman factor. It therefore appears possible that Factor XIa-HMW kininogen may represent an altemative mechanism for the enzymatic activation of Hageman factor and contribute to the gradual activation observed upon exposure of prekallikrein-deficient plasma to negatively charged surfaces.
